whether it's okay to use the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" indications
April 2013
You'll get questions about whether it's okay to use the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" indications.
All are approved to prevent stroke in atrial fib and to prevent clots after hip or knee surgery.
Xarelto (rivaroxaban) is also approved to treat deep vein thrombosis without symptomatic pulmonary embolism.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive